Patients
30.0 % of people
People aged 65 and over, Japan, 2025 (World Bank).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
Japan Hearing Aids (OTC) Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$195.7 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $95.9 Mn | — | — |
| 2025 (base) | $107.6 Mn | +$11.7 Mn | — |
| 2026 (forecast) | $120.8 Mn | +$13.1 Mn | +12.2% |
| 2027 (forecast) | $135.5 Mn | +$14.7 Mn | +25.9% |
| 2028 (forecast) | $152.0 Mn | +$16.5 Mn | +41.2% |
| 2029 (forecast) | $170.6 Mn | +$18.5 Mn | +58.5% |
| 2030 (forecast) | $191.4 Mn | +$20.8 Mn | +77.8% |
| 2031 (forecast) | $214.7 Mn | +$23.3 Mn | +99.5% |
| 2032 (forecast) | $240.9 Mn | +$26.2 Mn | +123.8% |
| 2033 (forecast) | $270.3 Mn | +$29.4 Mn | +151.2% |
| 2034 (forecast) | $303.3 Mn | +$33.0 Mn | +181.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $107.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $303.3 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 12.2% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product and channel (see all) |
| Key players | Sonova Holding AG, WS Audiology, GN Store Nord, Eargo, Apple Inc. and 1 more (see all) |
| Regulator in Japan | PMDASource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Over-the-counter hearing aids are sold directly to adults with mild to moderate hearing loss, without a prescription or fitting by a specialist.
Key segments of the hearing Aids (OTC) market include product (Behind-the-Ear, In-the-Ear and Earbud-Style) and channel (Retail Pharmacies, Online and Electronics Stores).
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the hearing Aids (OTC) market. Older adults and their families are spending more on staying active and independent.
Preventive care, personalised plans based on biomarkers and home-based services give the hearing Aids (OTC) market room to grow, especially in fast-ageing countries in Asia and Europe.
Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the hearing Aids (OTC) market.
The hearing Aids (OTC) market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare.[1] Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices).[2] People aged 65 and over: 30.0% of people in 2025, the latest World Bank figure for Japan.[3]
[1] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
[2] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hearing Aids (OTC) products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Japan.
What doctors and scientists are doing in Hearing Aids (OTC) right now, from free public sources.
30.0 % of people
People aged 65 and over, Japan, 2025 (World Bank).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 17 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
From our blog
Japan · 1 shared keyword
Japan · 1 shared keyword
Japan · 1 shared keyword
Japan · 1 shared keyword
Japan · 1 shared keyword
Japan · 1 shared keyword
Healthcare Services · Japan
Digital Health · Japan
Pharmaceuticals · Japan
Digital Health · Japan
Healthcare Services · Japan
OTC & Nutraceuticals · Japan